Ziekenhuis Nij Smellinghe — Clinical Trial Site

12 Registered trials

6 Currently recruiting

Organisation

Ziekenhuis Nij Smellinghe

Location

Drachten, Netherlands

Identifier

ORG-100045956

Address

Compagnonsplein 1, 9202 NN, Netherlands

Departments

Anesthesiology and Intensive Care
Internal Medicine
Internal Medicine/Hemato-Oncology
Internal medicine/Oncology
Internal Oncology
Interne geneeskunde
Medische Oncologie
Oncology
Surgery

Clinical trials at this site (12)

Search interface

Adjuvant Pembrolizumab in patients with early-stage triple negative breast cancer with residual disease after treatment with chemotherapy an… Pending

2025-524229-41-00 Triple negative breast cancer 5
The Intensive Care Platform Trial (INCEPT) Recruiting

2024-516208-41-00 Acute critical illness requiring intensive care unit ad 6 2025-06-26
A clinical study of ifinatamab deruxtecan to treat metastatic prostate cancer (MK 2400 01A) Recruiting

2024-516036-94-00 Metastatic castrate resistant prostate cancer - mCRPC 9 2025-08-12
DAROTAXEL Recruiting

2024-516939-28-00 metastatic castration-resistant prostate cancer 4 2024-10-28
FeAsiBility of a treatment free interval in newly diagnosed mUltiple myeLOma patients treated with DaratumUmab-Lenalidomide-DexamethaSone – … Recruiting

2023-508586-33-00 multiple myeloma 5 2024-05-14
Renal Lifecycle Trial: A Randomized Controlled Clinical Trial to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in … Recruiting

2023-508389-13-00 Combined endpoint of all-cause mortality, kidney failur 5 2022-11-08
DRUP trial Recruiting

2023-509152-33-00 Advanced solid tumor 4 2016-07-25
POEM Study Ended

2024-519386-21-01 Gestational diabetes mellitus 5 2025-01-29
Liposomal iRInotecan, Carboplatin or oXaliplatin in the first line treatment of esophagogastric cancer: a randomized phase 2 study (LyRICX) Ended

2023-509287-26-00 previously untreated metastatic or locally advanced eso 4 2019-07-01
Image‐guided de‐escalation of neoadjuvant chemotherapy in HER2‐positive breast cancer: the TRAIN‐3 study Ended

2024-516205-23-00 Breast cancer 4 2019-04-09
Endocrine therapy plus CDK 4/6 inhibition in first- or second-line for hormone receptor positive advanced breast cancer - the SONIA study Ended

2024-516204-42-00 Breast cancer 5 2017-11-21
A Phase III double-blind placebo-controlled Randomised Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients Ended

2022-502324-48-00 Patients with resected colon carcinoma 5 2014-08-05